Dr Ghssemi Ali Associate Professor of Pediatric Hematologist & Oncologist & stem cell transplantation.

Slides:

Advertisements

Similar presentations

Aydan Kansu, MD Ankara University School of Medicine, Department of Pediatric Gastroenterology and Hepatology, Turkey Field Study by the POINT-OF- CARE.

Advertisements

Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.

Congenital Neutropenia: Making the Decision to Transplant John E. Levine, MD, MS University of Michigan Blood and Marrow Transplantation Program.

Bone Marrow Transplant in Oncology

University of Wisconsin Newborn Screening for SCID Experience: Spanning the Spectrum Christine Seroogy MD Associate Professor Pediatric Allergy, Immunology.

BY DR IHEANACHO O.E..  Biodata  Male, 15years, student.  Diagnosis  SCA  Treatment  HSCT  HLA-matched sibling donor.  RIC using Flu/Bu.

Successful allogeneic SCT in infant with FHL, dilemmas in using „unaffected“ sibling P.Sedláček, R. Špíšek, et al 2nd Medical School, Charles University,

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.

Building Canada’s National Public Cord Blood Bank.

What about stem cell transplantation? Dr Catherine Flynn Consultant Haematologist St James’s Hospital 17/06/2011.

The Medical Mystery of Sasha Fierce By: Doctors Vanessa L’Abbate, Sarah Danzinger and Lydia Torres.

Our Commitment to Patients and Transplant Recipients Dr. Butchi Paidipaity, MD.

LIBYAN EXPERIENCE IN PEDIATRIC ACUTE MYELOID LEUKEMIA Fathia El Riani, Rasem Al Ajnef, Elham Sbita, Salem Zarroug Departement of pediatric hematology-oncology.

Successful sequential cord blood stem cell transplant and intestinal-colon transplant for combined immunodeficiency and intestinal failure.

Treatment of CML. Goal of Therapy Complete molecular remission and cure – Achieve prolonged, durable, nonneoplastic, nonclonal hematopoiesis, – Eradication.

Daunorubicin VS Mitoxantrone VS Idarubicin As Induction and Consolidation Chemotherapy for Adults with Acute Myeloid Leukemia : The EORTC and GIMEMA Groups.

HAPLOIDENTICAL STEM CELL TRANSPLANT

Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.

Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies.

At NH, We Have A Dream, A dream of making high quality health care affordable.

Dr. Kasi Viswanathan, Head Dept. Of Haematology & Bone marrow transplantation Dept. Of Pediatric Oncology, Meenakshi Mission Hospital & Research Centre,

Bone Marrow Transplant

Paediatric Cases for OSCE

DONATING BLOOD WHY IS IT IMPORTANT FOR ME TO DONATE BLOOD?

Hematopoietic Stem Cell Transplantation in Australia and New Zealand,

RIC UCBT Transplantation of Umbilical Cord Blood from Unrelated Donors in Patients with Haematological Diseases using a Reduced Intensity Conditioning.

NEONATAL IMMUNE THROMBOCYTOPENIA

Haematopoietic stem cell transplantation alongside enzyme replacement therapy in infantile onset lysosomal acid lipase deficiency Ghosh A1, Lum SH2, Jones.

From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study Ann Intern Med. 2004;140(2):85-93.

Malignancies in patients less than 6 months at MAHAK hospital

Case Western Reserve University and University Hospitals of Cleveland

EBMT Activity Survey Teams Patients Transplants

CASE PRESENTATION DR SANJAY MAITRA, DR DENISH SAVALIA,

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.

5/23/2013 hammoud.

EBMT Activity Survey Teams 39,313 Patients 43,636 Transplants

EBMT Activity Survey Teams Patients Transplants

TITLE Authors LOGO INTRODUCTION IMAGING/HISTOLOGY PATIENT DESCRIPTION

PREDICTIVE FACTORS AFFECTING THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION USING RIC REGIMENS: EXPERIENCE FROM A SINGLE CENTRE Dott.ssa M. Medeot.

Vaccination of Children following Allogeneic Stem Cell Transplantation

Diagnostic Hematology

by Kenneth Weinberg, Bruce R. Blazar, John E

by Jayesh Mehta Blood Volume 112(2): July 15, 2008

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION for MULTIPLE MYELOMA

Interesting case conference

Leukemia case 5.

Introduction Case Report Conclusion

Figure 2 Components of each transplantation platform

Letermovir(Prevymis™) Guidelines for Inpatient Use

Dynamics of the Emergence of a Human Cytomegalovirus UL97 Mutant Strain Conferring Ganciclovir Resistance in a Pediatric Stem-Cell Transplant Recipient

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation,

Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma Jessica Rueff, Michael Medinger,

Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program Margaret L.

Kasiani C. Myers, Stella M. Davies

Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe Shahram.

Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring.

Beta thalasemia.

An Exploratory Analysis of Mitochondrial Haplotypes and Allogeneic Hematopoietic Cell Transplantation Outcomes Julie A. Ross, Jakub Tolar, Logan G. Spector,

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.

Hematopoietic Stem Cell Transplantation Dr . Ghassemi A Associate professor of pediatric Hematologist Oncologist & stem cell transplantation.

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched.

Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.

Bridge to transplant following Bv+Bs regimen.

Hematopoietic Stem Cell Transplantation in Australia and New Zealand,

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based.

Overview of the treatment protocol HLH-94

Survival after HLA-Matched Sibling Donor HCT for ALL, Age ≥18 Years,

How I treat acquired aplastic anemia

by Jennifer N. Brudno, and James N. Kochenderfer

Presentation transcript:

Dr Ghssemi Ali Associate Professor of Pediatric Hematologist & Oncologist & stem cell transplantation

BMT in Montasrieh Hospital,MUMS NO Patients:73 Allogenic:54= %75 Autologous=18=%25

3 Months old girl prolong fever. 1month 3 Months old girl prolong fever .1month .post vaccination CBC: thrombocytopenia Hepatosplenomegaly

History of death in previous baby BMA x2 = normal Acid fast staining was normal Treatment with HLH protocole

Father, mother and other sibling didn’t match in HLA Extended family search performed

Donor: male 40 years old Father's uncle Mother's uncle Date of BMT= 7/7/1394 BG= A+ Recipient = Girl 7month BG=O+

Stem cell phresis=200ml TNC=26 x 108/kg MNC = 22 Stem cell phresis=200ml TNC=26 x 108/kg MNC = 22.1 x 108/kg Infusion MNC= 8 x 108/kg

Conditioning regime FLU 5 day ATG 4 day Melphalan 2 day

Recovery Neut +11 WBC= 1100, Neut=66% PLT= 45000 +11 Discharge= +14 duration = 25

آخرین CBC 96/6/7 WBC=11000 Hb=12/1 Plt=235000